Citius Oncology, Inc. CTOR

Set alert

Price alert · CTOR

All alert types
0.59 USD +0.04 +7.24%

At close · Nov 2

0.60 +0.01 +1.72%

After hours · Nov 2, 4:00 PM ET

Bid
0.59 × 1
Ask
0.61 × 2
0.5535 Day range 0.694
0.491 52-week range 1.83
YTD
-40.59%
1 year
-66.05%
Open
0.589
Prev close
0.554
Mkt cap
62.83M
Vol
378.70K
Avg vol
124.45K
EPS
-0.48
P/E
0.00
Div yield
0.00%
More statistics
Low
0.5535
High
0.694
Forward P/E
0.00
Beta
0.00
Short ratio
0.37
Inst. own
0.70%
Dividend
0.00
Ex-div date
50-d avg
1.13
200-d avg
7.55
1y target
3.00

6M chart

Chart tools
Interval

Signals (29)
NameDateAgo
RSI: OversoldOct 28, 20265 days ago
RSI: OversoldOct 23, 20261 week ago
RSI: OversoldOct 20, 20261 week ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BearishOct 8, 20263 weeks ago
MACD: Sell SignalSep 30, 20261 month ago
RSI: OverboughtSep 18, 20261 month ago
MACD: Buy SignalSep 4, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalAug 31, 20262 months ago
SMA: BullishAug 25, 20262 months ago
SMA: BearishAug 21, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BearishAug 17, 20262 months ago
RSI: OverboughtAug 14, 20262 months ago
SMA: BullishAug 12, 20262 months ago
SMA: BearishAug 11, 20262 months ago
SMA: BullishAug 5, 20262 months ago
SMA: BullishAug 5, 20262 months ago

Newest 20 of 29.

Analyst view

Consensus: none

Price target (mean) 3.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CTOR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%00.0%0
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year0.000.00 – 0.000.000.0%00.0%0
Next year0.000.00 – 0.000.000.0%28.68M0.0%0

Upgrades and downgrades

The latest rating changes

CTOR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 27, 2024Maxim GroupInitiated—Buy
Aug 13, 2024EF HuttonMaintainedBuyBuy